Context While assessing symptom severity is an important component of evaluating
symptoms, understanding those symptoms that interfere with patients' lives is also key …

Background. Health‐related quality of life (HRQoL) impairment is common in pulmonary
hypertension (PH), but its clinical predictors are not well established. This study aims to …

Background Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary
artery pressures leading to right heart failure and death. Aims The aim of this study was to …

Study objectives: Patients with pulmonary arterial hypertension (PAH) often present with
dyspnea and severe functional limitations, but their health-related quality of life (HRQOL) …

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that
negatively impacts health‐related quality of life (HRQOL). The PAH‐symptoms and impact …

Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive
disease. Although there have been important medical advances in PAH management, the …

BACKGROUND: Pulmonary arterial hypertension (PAH) remains a debilitating and life-
threatening disease despite improvements in hemodynamics, exercise capacity and survival …

Pulmonary arterial hypertension (PAH) is a debilitating disease that pervades all aspects of
a patient's daily life. It is also increasingly acknowledged that the burden of PAH extends to …

PAH is a rare, incurable, and progressive disease caused by an increase in pulmonary
vascular resistance at the precapillary level. 1–3 In a survey of national registries and expert …

Pulmonary arterial hypertension (PAH) is a chronic progressive devastating disease.
Symptom burden might impair health-related quality of life of patients. Furthermore …